胎盘植入谱系疾病的分娩时机:延迟分娩是可行的
本研究比较了产前疑似胎盘植入谱系疾病患者按指征提早分娩与计划延迟至36 0/7周后分娩的母婴结局。延迟分娩组新生儿结局更好,母体结局无差异,提示在具备条件的中心可计划于晚孕期或早期足月分娩。
要点
- 产前疑似胎盘植入谱系疾病若无其他分娩指征,可计划在36 0/7周后分娩。
- 延迟分娩不增加母体不良结局,但改善新生儿结局。
- 提早分娩组母体全血输注更多,新生儿并发症与早产相关。
核心结论
- 对于无出血、临产、胎膜早破或子痫前期等其他分娩指征的产前疑似胎盘植入谱系疾病患者,可在邻近患者的专科中心计划于晚孕期或早期足月分娩。
- 延迟分娩不影响母体结局,但改善新生儿结局。
研究设计与样本
- 本研究为单中心研究,纳入2009年8月至2022年4月期间孕周≥24 0/7周且产前疑似胎盘植入谱系疾病的妊娠。
- 共纳入202例患者,按分娩时机分为36 0/7周后分娩组与在此之前分娩组,比较母婴结局。
- 统计分析采用χ2检验分类变量和Student t检验连续变量。
主要发现
- 202例产前疑似胎盘植入谱系疾病患者中,65例(32%)有提早分娩指征,137例(68%)计划在36 0/7周后分娩。
- 有指征组分娩中位孕周为35周(四分位距31-36),无并发症组为37周(四分位距36-37)(P<.001)。
- 有指征组中42例(65%)因出血分娩,11例(17%)因临产分娩,12例(18%)因其他指征分娩。
- 有指征组全血输注量中位数为0(四分位距0-6),无指征组为0(四分位距0-4)(P=.007);有指征组血小板输注量中位数为0(四分位距0-6),无指征组为0(四分位距0-10)(P=.021)。
- 有指征组新生儿更可能出现低出生体重、新生儿重症监护病房入住、呼吸窘迫综合征、需要机械通气和住院时间延长,均可能继发于早产。
临床怎么用
- 本研究中心的做法是,对于无其他合并症的产前疑似胎盘植入谱系疾病妊娠,历来计划在36 0/7至37 6/7周分娩。
- 本研究中心在紧急情况下更常使用全血输注。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Delivery at 34 0/7 to 35 6/7 weeks of gestation is recommended for patients with prenatally suspected placenta accreta spectrum. However, data supporting these recommendations are limited. As a large-volume tertiary care center, in an otherwise uncomplicated pregnancy with prenatal concerns for placenta accreta spectrum, we have historically planned delivery at 36 0/7 to 37 6/7 weeks of gestation. OBJECTIVE: This study aimed to describe the effect of delayed delivery on maternal and fetal outcomes in patients with suspected placenta accreta spectrum. STUDY DESIGN: This study examined pregnancies at ≥24 0/7 weeks of gestation complicated by prenatally suspected placenta accreta spectrum from August 2009 to April 2022. Maternal and neonatal outcomes were compared according to delivery timing (beyond 36 0/7 weeks vs prior to this gestational age). In addition, the indication for early delivery was determined. Statistical analysis used the χ2 test for categorical variables and the Student t test for continuous variables. RESULTS: Of 202 patients with prenatal concerns for placenta accreta spectrum, 65 (32%) had an early indication for delivery (bleeding, preeclampsia, premature rupture of membranes, or labor), whereas 137 (68%) had planned deliveries after 36 0/7 weeks of gestation for concern for placenta accreta spectrum. There was no difference in maternal age, race/ethnicity, parity, body mass index, or number of previous cesarean deliveries. The median gestational ages at delivery were 35 weeks (interquartile range, 31-36) in the indicated group and 37 weeks (interquartile range, 36-37) in the group without complications (P<.001). The prenatally suspected severity of placenta accreta spectrum did not differ between the groups or on pathology. Of the patients who delivered for indications, 42 (65%) delivered for bleeding, 11 (17%) delivered for labor, and 12 (18%) delivered for other indications. The only maternal outcome with a noted difference between the groups was increased whole blood transfusions (more commonly used at our institution in emergent situations) in patients with indicated deliveries (0 [interquartile range, 0-6] in the group with indications vs 0 [interquartile range, 0-4] in the group without indications; P=.007) and decreased platelet transfusions (0 [interquartile range, 0-6] in the group with indications vs 0 [interquartile range, 0-10] in the group without indications; P=.021). Neonates in the indicated cohort were more likely to have lower birthweights, neonatal intensive care unit admission, respiratory distress syndrome, need for mechanical ventilation, and longer hospital stays, all of which were likely secondary to prematurity. CONCLUSION: Patients with suspected placenta accreta spectrum without other indications for delivery, such as bleeding, labor, rupture of membranes, or preeclampsia, can have a planned delivery in the late preterm or early term period at specialized centers that are geographically in close proximity to the patient. Later delivery does not affect maternal outcomes but improves neonatal outcomes.
引用
- Rosenthal EA, White A, Lafferty AK, et al. Delivery timing of placenta accreta spectrum: later is feasible. Am J Obstet Gynecol. 2025. PMID: 39983888. doi:10.1016/j.ajog.2025.02.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。